SRIKANTH VANGAPANDU: Open Payments
NPI 1285009837 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,221 in 324 payments from 18 companies in 2025. Trend: 2023 $3,584 · 2024 $4,931 · 2025 $5,221
Food & beverage: $4,529Consulting: $500Education: $192
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 61 | $793 |
| Janssen Biotech, Inc. | 45 | $758 |
| Journey Medical Corporation | 10 | $560 |
| UCB, Inc. | 24 | $535 |
| PFIZER INC. | 22 | $354 |
| E.R. Squibb & Sons, L.L.C. | 23 | $330 |
| Lilly USA, LLC | 16 | $313 |
| Incyte Corporation | 38 | $278 |
| Arcutis Biotherapeutics, Inc. | 22 | $224 |
| Galderma Laboratories, L.P. | 19 | $212 |
Products named: TREMFYA, Bimzelx, SKYRIZI, RINVOQ, CIBINQO, Sotyktu, OPZELURA, TALTZ.
Industry payments across OH — which companies pay providers there.
